REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 186 filers reported holding REGENXBIO INC in Q2 2019. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $113,000 | -93.8% | 2,690 | -94.2% | 0.00% | -93.8% |
| Q2 2021 | $1,814,000 | +13.9% | 46,690 | 0.0% | 0.03% | +23.1% |
| Q1 2021 | $1,593,000 | +575.0% | 46,690 | +797.9% | 0.03% | +550.0% |
| Q4 2020 | $236,000 | +65.0% | 5,200 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $143,000 | -25.5% | 5,200 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $192,000 | +14.3% | 5,200 | 0.0% | 0.00% | -20.0% |
| Q1 2020 | $168,000 | -21.1% | 5,200 | 0.0% | 0.01% | +25.0% |
| Q4 2019 | $213,000 | +15.1% | 5,200 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $185,000 | 0.0% | 5,200 | +44.4% | 0.00% | 0.0% |
| Q2 2019 | $185,000 | -10.2% | 3,600 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $206,000 | -51.3% | 3,600 | -50.0% | 0.00% | -20.0% |
| Q4 2018 | $423,000 | +55.5% | 7,200 | +100.0% | 0.01% | -16.7% |
| Q3 2018 | $272,000 | – | 3,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic GP LLC | 743,079 | $14,854,149 | 9.91% |
| Aquilo Capital Management, LLC | 870,114 | $17,393,579 | 9.64% |
| MPM BioImpact LLC | 656,718 | $13,127,793 | 2.64% |
| ArchPoint Investors | 224,278 | $4,483,317 | 1.73% |
| Redmile Group, LLC | 2,026,576 | $40,511,254 | 1.56% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 35,396 | $707,566 | 1.36% |
| WS MANAGEMENT LLLP | 795,778 | $15,907,602 | 1.33% |
| Redwood Wealth Management Group, LLC | 14,760 | $295,052 | 0.33% |
| SummerHaven Investment Management, LLC | 21,298 | $425,747 | 0.27% |
| HARBOR CAPITAL ADVISORS, INC. | 44,106 | $881,679 | 0.18% |